Gyre Therapeutics
GYRE
GYRE
49 hedge funds and large institutions have $55.3M invested in Gyre Therapeutics in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $66.4M → $55.3M (-$11.1M)
22% less funds holding
Funds holding: 63 → 49 (-14)
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
Holders
49
Holding in Top 10
1
Calls
$196K
Puts
$118K
Top Buyers
| 1 | +$5.25M | |
| 2 | +$1.73M | |
| 3 | +$976K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$624K |
| 5 |
Goldman Sachs
New York
|
+$595K |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$2.34M | |
| 3 | -$2.08M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.58M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.31M |